xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS). IDE approval enables the company to initiate a pivotal clinical trial evaluating the AMS for the closure of femoral arterial and femoral venous access sites. The company plans to enroll patients undergoing … [Read more...] about xDot Medical can begin FDA IDE study of vascular closure device
